MedPath

成都中核高通同位素股份有限公司

Ownership
-
Established
2002-06-11
Employees
-
Market Cap
-
Website
https://www.cngt.com.cn

Clinical Trials

0

Active:0
Completed:0

Trial Phases

0 Phases

Drug Approvals

15

NMPA:15

Drug Approvals

Strontium[89Sr] Chloride Injection

Product Name
氯化锶[89Sr]注射液
Approval Number
国药准字H20080471
Approval Date
Feb 6, 2024
NMPA

Strontium[89Sr] Chloride Injection

Product Name
氯化锶[89Sr]注射液
Approval Number
国药准字H20080474
Approval Date
Jan 9, 2023
NMPA

Strontium[89Sr] Chloride Injection

Product Name
氯化锶[89Sr]注射液
Approval Number
国药准字H20080473
Approval Date
Jan 9, 2023
NMPA

Strontium[89Sr] Chloride Injection

Product Name
氯化锶[89Sr]注射液
Approval Number
国药准字H20080472
Approval Date
Jan 9, 2023
NMPA

Sodium Pertechnetate [99mTc] Injection(99mTcO4)

Product Name
高锝[99mTc]酸钠注射液(99Mo—99mTc发生器)
Approval Number
国药准字H10960089
Approval Date
Jun 17, 2020
NMPA

Sodium Pertechnetate [99mTc] Injection(99mTcO4)

Product Name
高锝[99mTc]酸钠注射液(99Mo—99mTc发生器)
Approval Number
国药准字H10960091
Approval Date
Jun 17, 2020
NMPA

Sodium Pertechnetate [99mTc] Injection(99mTcO4)

Product Name
高锝[99mTc]酸钠注射液(99Mo—99mTc发生器)
Approval Number
国药准字H10960090
Approval Date
Jun 17, 2020
NMPA

Sodium Iodohippurate [131I] Injection

Product Name
邻碘[131I]马尿酸钠注射液
Approval Number
国药准字H10983125
Approval Date
Jun 1, 2020
NMPA

Sodium Iodide[131I]Oral Solution

Product Name
碘[131I]化钠口服溶液
Approval Number
国药准字H10983120
Approval Date
Jun 1, 2020
NMPA

Sodium Iodohippurate [131I] Injection

Product Name
邻碘[131I]马尿酸钠注射液
Approval Number
国药准字H10983123
Approval Date
Jun 1, 2020
NMPA
  • Prev
  • 1
  • 2
  • Next

Clinical Trials

No trials found

News

No news found
© Copyright 2025. All Rights Reserved by MedPath